San Diego, California: August 28, 2006 — Synbiotics Corporation today announced that it is relocating its corporate headquarters and research & development facilities to Kansas City, Missouri. Synbiotics was founded in San Diego in 1982 and has become a leading veterinary diagnostic firm which develops, manufacturers and markets veterinary diagnostics, instrumentation and related products and services for the poultry, livestock and companion animal markets worldwide. Synbiotics is an expert in avian influenza surveillance and early detection. Synbiotics maintains two manufacturing operations, one each in San Diego, California and Lyon, France.

“We began a search late in the 4th quarter of last year to relocate our headquarters and R&D functions to be closer to our customer base, to universities excelling in veterinary research and to potential collaborators in the form of veterinary vaccine manufacturers. Considering Kansas City’s concentration of animal health companies, technology and resources was very appealing to us,” said Paul Hays, Synbiotics’ President and CEO at Synbiotics Corp. “We knew this is where we needed to be.”

“The abundance and quality of educated and trained scientists and skilled workforce available to us by locating to the Kansas City area was very important to our decision,” said Hays. “The numerous area universities with veterinary colleges performing world-class research into the immunology and molecular biology of animal diseases provides opportunities for Synbiotics to hire trained professionals and license or acquire cutting edge technology”

The company is negotiating final lease terms for space in a local commercial facility. It is estimated that the relocation will be completed by March 2007. The company intends to bring approximately 35 management and research jobs here immediately and will likely add another 10 over the next few years. Synbiotics has 112 employees world-wide today.

Synbiotics Corporation develops, manufactures and markets veterinary diagnostics, instrumentation and related products for the poultry, livestock and companion animal, markets worldwide. Synbiotics is an expert in avian influenza surveillance and early detection. Synbiotics manufactures and distributes its products through its operations in San Diego, California, and Lyon, France. For information on Synbiotics and its products, visit the Company’s website at www.synbiotics.com.

With the exception of historical matters, the issues discussed in this press release are forward-looking statements that are subject to the risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements, including competition from larger companies, reliance on third-party manufacturers and distributors and possible technology improvements by others. These forward-looking statements represent Synbiotics Corporation's judgment as of the date of the release. Synbiotics Corporation disclaims, however, any intent or obligation to update these forward-looking statements.

San Diego, California: August 21, 2006 — Synbiotics Corporation today announced that it recorded a 7 percent increase in revenues for the first six months of 2006 compared with the same period in 2005. Revenues for the first six months totaled $10,815,000 compared with $10,140,000 for the same period last year. Sales growth was lead by the company’s avian influenza line.

Paul Hays, Synbiotics' President and Chief Executive Officer, said, “Our flu portfolio has demonstrated that Synbiotics is a leader in the area of flu diagnostics. Our Flu Detect® avian influenza type A antigen test strip and ProFLOK® AIV Plus avian influenza antibody ELISA test kits have been well received by poultry producers, veterinary diagnostic laboratories and public health organizations throughout the world.”

Operating expenses for the first half year 2006 were significantly reduced due to savings realized through costs spared as a result of key efforts implemented in 2005 including: the company now being private, the restructuring of debt and the reorganization within French affiliate, Synbiotics Europe SAS.

"We are very pleased with our results. Clearly the programs we implemented in 2005 have achieved the intended result,” Hays said.

Synbiotics Corporation develops, manufactures and markets veterinary diagnostics, instrumentation and related products for the poultry, livestock and companion animal markets worldwide. Synbiotics manufactures and distributes its products through its operations in San Diego, California, and Lyon, France. For information on Synbiotics and its products, visit the Company’s website at www.synbiotics.com.

With the exception of historical matters, the issues discussed in this press release are forward-looking statements that are subject to the risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements, including competition from larger companies, reliance on third-party manufacturers and distributors and possible technology improvements by others. These forward-looking statements represent Synbiotics Corporation's judgment as of the date of the release. Synbiotics Corporation disclaims, however, any intent or obligation to update these forward-looking statements.